Cas 898537-59-2,1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-chloro-pyrimidin-4-yloxy)-phenyl]-urea

898537-59-2

Post Buying Request

Basic information

Product Name: 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-chloro-pyrimidin-4-yloxy)-phenyl]-urea
Synonyms: 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-chloro-pyrimidin-4-yloxy)-phenyl]-urea
CAS NO:898537-59-2
Molecular Formula:
Molecular Weight: 476.966
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-chloro-pyrimidin-4-yloxy)-phenyl]-urea(CAS DataBase Reference)
NIST Chemistry Reference: 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-chloro-pyrimidin-4-yloxy)-phenyl]-urea(898537-59-2)
EPA Substance Registry System: 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-chloro-pyrimidin-4-yloxy)-phenyl]-urea(898537-59-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 898537-59-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

898537-59-2 Suppliers

Recommended suppliers

898537-59-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 898537-59-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,8,5,3 and 7 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 898537-59:
(8*8)+(7*9)+(6*8)+(5*5)+(4*3)+(3*7)+(2*5)+(1*9)=252
252 % 10 = 2
So 898537-59-2 is a valid CAS Registry Number.

898537-59-2Upstream product

898537-59-2Downstream Products

898537-59-2Relevant academic research and scientific papers

DISUBSTITUTED UREAS AS KINASE INHIBITORS

-

Page/Page column 15, (2009/05/28)

The invention relates to compounds of the formula (I), their use as kinase inhibitors, new pharmaceutical formulations comprising said compounds, said compounds for use in the diagnostic or therapeutic treatment of warm-blooded animals, especially humans,

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 898537-59-2